• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

A new storm on the horizon in COVID-19: Bradykinin-induced vascular complications.

作者信息

McCarthy Cameron G, Wilczynski Stephanie, Wenceslau Camilla F, Webb R Clinton

机构信息

Center for Hypertension and Personalized Medicine, 3000 Arlington Ave, Toledo, OH 43614-2598, USA; Department of Physiology & Pharmacology, University of Toledo College of Medicine and Life Sciences, Toledo, OH, United States of America.

Cardiovascular Translational Research Center, 6311 Garners Ferry Road, Columbia, SC 29209, United States of America; Department of Cell Biology and Anatomy, University of South Carolina School of Medicine, Columbia, SC, United States of America.

出版信息

Vascul Pharmacol. 2021 Apr;137:106826. doi: 10.1016/j.vph.2020.106826. Epub 2021 Jan 13.

DOI:10.1016/j.vph.2020.106826
PMID:33358968
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7834250/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b91/7834250/c1c0227f461d/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b91/7834250/c1c0227f461d/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b91/7834250/c1c0227f461d/gr1_lrg.jpg

相似文献

1
A new storm on the horizon in COVID-19: Bradykinin-induced vascular complications.新型冠状病毒肺炎（COVID-19）即将出现的一场新风暴：缓激肽诱导的血管并发症。
Vascul Pharmacol. 2021 Apr;137:106826. doi: 10.1016/j.vph.2020.106826. Epub 2021 Jan 13.
2
Endothelial cells and SARS-CoV-2: An intimate relationship.内皮细胞与 SARS-CoV-2：一种密切的关系。
Vascul Pharmacol. 2021 Apr;137:106829. doi: 10.1016/j.vph.2021.106829. Epub 2021 Jan 8.
3
Endothelial dysfunction in COVID-19: a position paper of the ESC Working Group for Atherosclerosis and Vascular Biology, and the ESC Council of Basic Cardiovascular Science.新型冠状病毒肺炎中的血管内皮功能障碍：欧洲心脏病学会动脉粥样硬化和血管生物学工作组以及欧洲心脏病学会心血管基础科学理事会立场文件。
Cardiovasc Res. 2020 Dec 1;116(14):2177-2184. doi: 10.1093/cvr/cvaa230.
4
SARS-CoV-2 Spike Protein Destabilizes Microvascular Homeostasis.SARS-CoV-2 刺突蛋白破坏微血管内稳态。
Microbiol Spectr. 2021 Dec 22;9(3):e0073521. doi: 10.1128/Spectrum.00735-21.
5
COVID-19 - A vascular disease.COVID-19 - 一种血管疾病。
Trends Cardiovasc Med. 2021 Jan;31(1):1-5. doi: 10.1016/j.tcm.2020.10.005. Epub 2020 Oct 14.
6
Des-Arg9 bradykinin and bradykinin potentially trigger cytokine storm in patients with COVID-19.去-精氨酸9缓激肽和缓激肽可能会引发新冠肺炎患者的细胞因子风暴。
Iran J Immunol. 2021 Mar;18(1):93-94. doi: 10.22034/iji.2021.89684.1962.
7
Cutaneous Endothelial Dysfunction and Complement Deposition in COVID-19.新型冠状病毒肺炎中的皮肤内皮功能障碍与补体沉积
Am J Dermatopathol. 2021 Mar 1;43(3):237-238. doi: 10.1097/DAD.0000000000001825.
8
The implications of COVID-19 infection on the endothelium: A metabolic vascular perspective.2019冠状病毒病感染对内皮的影响：代谢性血管视角
Diabetes Metab Res Rev. 2021 Mar;37(3):e3402. doi: 10.1002/dmrr.3402. Epub 2020 Sep 9.
9
Bradykinin as a Probable Aspect in SARS-Cov-2 Scenarios: Is Bradykinin Sneaking out of Our Sight?缓激肽可能是新冠病毒感染情况中的一个因素：缓激肽是否在我们的视线中悄然溜走？
Iran J Allergy Asthma Immunol. 2020 May 17;19(S1):13-17. doi: 10.18502/ijaai.v19i(s1.r1).2850.
10
Noscapine, a possible drug candidate for attenuation of cytokine release associated with SARS-CoV-2.纳库巴碱，一种可能的候选药物，可减轻与 SARS-CoV-2 相关的细胞因子释放。
Drug Dev Res. 2020 Nov;81(7):765-767. doi: 10.1002/ddr.21676. Epub 2020 Apr 26.

引用本文的文献

1
COVID-19: Unveiling the Neuropsychiatric Maze-From Acute to Long-Term Manifestations.新冠病毒病（COVID-19）：揭示神经精神困境——从急性到长期表现
Biomedicines. 2024 May 22;12(6):1147. doi: 10.3390/biomedicines12061147.
2
In Silico Analyses Indicate a Lower Potency for Dimerization of TLR4/MD-2 as the Reason for the Lower Pathogenicity of Omicron Compared to Wild-Type Virus and Earlier SARS-CoV-2 Variants.计算机分析表明，与野生型病毒和早期 SARS-CoV-2 变体相比，奥密克戎的 TLR4/MD-2 二聚化亲和力较低，这可能是其致病性较低的原因。
Int J Mol Sci. 2024 May 17;25(10):5451. doi: 10.3390/ijms25105451.
3
Impact of the SARS-CoV-2 Spike Protein on the Innate Immune System: A Review.

本文引用的文献

1
SARS-CoV-2 receptor is co-expressed with elements of the kinin-kallikrein, renin-angiotensin and coagulation systems in alveolar cells.SARS-CoV-2 受体与肺泡细胞中的激肽-激肽释放酶、肾素-血管紧张素和凝血系统成分共表达。
Sci Rep. 2020 Nov 11;10(1):19522. doi: 10.1038/s41598-020-76488-2.
2
Mast Cells in Alveolar Septa of COVID-19 Patients: A Pathogenic Pathway That May Link Interstitial Edema to Immunothrombosis.COVID-19 患者肺泡隔中的肥大细胞：一种可能将间质水肿与免疫血栓联系起来的致病途径。
Front Immunol. 2020 Sep 18;11:574862. doi: 10.3389/fimmu.2020.574862. eCollection 2020.
3
COVID-19 is, in the end, an endothelial disease.
严重急性呼吸综合征冠状病毒2刺突蛋白对固有免疫系统的影响：综述
Cureus. 2024 Mar 26;16(3):e57008. doi: 10.7759/cureus.57008. eCollection 2024 Mar.
4
COVID-19: Not a thrombotic disease but a thromboinflammatory disease.COVID-19：不是血栓性疾病，而是血栓炎症性疾病。
Ups J Med Sci. 2024 Jan 22;129. doi: 10.48101/ujms.v129.9863. eCollection 2024.
5
Protection against Severe Illness versus Immunity-Redefining Vaccine Effectiveness in the Aftermath of COVID-19.预防重症与免疫——重新定义新冠疫情后的疫苗效力
Microorganisms. 2023 Jul 31;11(8):1963. doi: 10.3390/microorganisms11081963.
6
Minireview: functional roles of tissue kallikrein, kinins, and kallikrein-related peptidases in lung cancer.综述：组织激肽释放酶、激肽及激肽释放酶相关肽酶在肺癌中的功能作用
Med Oncol. 2023 Jul 5;40(8):224. doi: 10.1007/s12032-023-02090-x.
7
Long COVID in children and adolescents: prevalence, clinical manifestations, and management strategies.儿童和青少年的长期新冠：患病率、临床表现及管理策略
Clin Exp Pediatr. 2023 Nov;66(11):465-474. doi: 10.3345/cep.2023.00472. Epub 2023 Jun 19.
8
Immune Response and Molecular Mechanisms of Cardiovascular Adverse Effects of Spike Proteins from SARS-CoV-2 and mRNA Vaccines.新冠病毒刺突蛋白及mRNA疫苗心血管不良反应的免疫反应与分子机制
Biomedicines. 2023 Feb 3;11(2):451. doi: 10.3390/biomedicines11020451.
9
The des-Arg-bradykinin/B1R axis: Hepatic damage in COVID-19.去精氨酸缓激肽/B1R轴：新冠病毒感染中的肝损伤
Front Physiol. 2022 Dec 19;13:1080837. doi: 10.3389/fphys.2022.1080837. eCollection 2022.
10
Impaired Kallikrein-Kinin System in COVID-19 Patients' Severity.新冠肺炎患者严重程度的激肽释放酶-激肽系统受损。
Front Immunol. 2022 Jun 22;13:909342. doi: 10.3389/fimmu.2022.909342. eCollection 2022.
COVID-19 归根结底是一种血管内皮疾病。
Eur Heart J. 2020 Sep 1;41(32):3038-3044. doi: 10.1093/eurheartj/ehaa623.
4
A mechanistic model and therapeutic interventions for COVID-19 involving a RAS-mediated bradykinin storm.涉及 RAS 介导的缓激肽风暴的 COVID-19 的机械模型和治疗干预。
Elife. 2020 Jul 7;9:e59177. doi: 10.7554/eLife.59177.
5
COVID-19: the vasculature unleashed.COVID-19：血管失控。
Nat Rev Immunol. 2020 Jul;20(7):389-391. doi: 10.1038/s41577-020-0343-0.
6
Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome.COVID-19 患者的激肽释放酶-激肽系统阻断治疗以预防急性呼吸窘迫综合征。
Elife. 2020 Apr 27;9:e57555. doi: 10.7554/eLife.57555.
7
Endothelial cell infection and endotheliitis in COVID-19.新型冠状病毒肺炎中的内皮细胞感染与内皮炎
Lancet. 2020 May 2;395(10234):1417-1418. doi: 10.1016/S0140-6736(20)30937-5. Epub 2020 Apr 21.
8
Bradykinin Receptors Play a Critical Role in the Chronic Post-ischaemia Pain Model.缓激肽受体在慢性缺血后疼痛模型中起关键作用。
Cell Mol Neurobiol. 2021 Jan;41(1):63-78. doi: 10.1007/s10571-020-00832-3. Epub 2020 Mar 28.
9
Attenuation of pulmonary ACE2 activity impairs inactivation of des-Arg bradykinin/BKB1R axis and facilitates LPS-induced neutrophil infiltration.肺组织 ACE2 活性降低可减弱无精氨酸缓激肽（des-Arg bradykinin）/BKB1R 轴的失活，并促进 LPS 诱导的中性粒细胞浸润。
Am J Physiol Lung Cell Mol Physiol. 2018 Jan 1;314(1):L17-L31. doi: 10.1152/ajplung.00498.2016. Epub 2017 Sep 21.
10
Kinin receptors: Key regulators of autoimmunity.激肽受体：自身免疫的关键调节因子。
Autoimmun Rev. 2017 Feb;16(2):192-207. doi: 10.1016/j.autrev.2016.12.011. Epub 2016 Dec 15.